As a result of the ICPT news, other pharmaceutical companies engaged in the research and development of treatments for liver diseases are trading higher.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.